NasdaqGS:MDGLBiotechs
Madrigal Equity Awards Highlight Shift From Development Story To Commercial Growth
Madrigal Pharmaceuticals (NasdaqGS:MDGL) granted inducement equity awards to 21 newly hired non executive employees.
The awards follow regulatory approval of the company’s lead MASH treatment, Rezdiffra, which is currently described as the first and only FDA and European Commission approved therapy for MASH with moderate to advanced fibrosis.
The grants are intended as material inducements to join Madrigal, aligning new hires with shareholder interests after recent regulatory...